Literature DB >> 6299187

Synthesis of some 5'-amino-2',5'-dideoxy-5-iodouridine derivatives and their antiviral properties against herpes simplex virus.

A F Markham, C R Newton, R A Porter, I S Sim.   

Abstract

In an attempt to improve the antiviral efficacy of 5'-amino-2',5'-dideoxy-5-iodouridine (AIdU) the N-acetyl and N,3'-O-diacetyl derivatives were prepared. N-Acetylation of AIdU increased its ability to inhibit the phosphorylation of thymidine by the deoxypyrimidine kinase of herpes simplex virus type 1 (HSV1) while diacetylation had the converse effect. The affinity of the corresponding compounds containing uracil or thymine for virus deoxypyrimidine kinase was also determined. A range of N-acyl-, N-sulphonyl- and N,3'-O-diacyl- derivatives of AIdU were synthesized; enhanced inhibition of deoxypyrimidine kinase by a number of these compounds was observed. The previous observation that 5'-azido-2',5'-dideoxy-5-iodouridine has antiherpetic activity in vivo led us to investigate its 3'-O-acetyl derivative as well as the corresponding compound containing uracil. None of the derivatives described showed antiviral activity in cell culture against HSV1; acylation failed to enhance the potency of AIdU against HSV1 in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6299187     DOI: 10.1016/0166-3542(82)90001-8

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  2 in total

1.  A Green Chemical Approach for Iodination of Pyrimidine Derivatives by Mechanical Grinding under Solvent-Free Conditions.

Authors:  Thananjeyan Balasubramaniyam; Byeong-Seon Kim; Badvel Pallavi; Ho-Seong Jin; Sung Kuk Kim; Joon-Hwa Lee
Journal:  Molecules       Date:  2022-09-27       Impact factor: 4.927

2.  Synthesis and antiviral evaluation of acyclic azanucleosides developed from sulfanilamide as a lead structure.

Authors:  Rafał Gawin; Erik De Clercq; Lieve Naesens; Mariola Koszytkowska-Stawińska
Journal:  Bioorg Med Chem       Date:  2008-08-26       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.